ESR1 and breast carcinoma: Triple‐negative breast cancer (TNBC), defined as breast cancer that is estrogen receptor‐, progesterone receptor‐, and human epidermal growth factor receptor 2‐negative, accounts for 10%–15% of all breast cancers in Japan and is associated with a poor prognosis.4, 7, 8